Egenskap
Depression
Frequently experiencing feelings of being down, miserable, and/or hopeless; struggling to recover from these moods; having a pessimistic outlook on the future; feeling a pervasive sense of shame; having a low self-worth; experiencing thoughts of suicide and engaging in suicidal behavior.
Sammendrag
- Også kalt
- Depressive episode, Depressivity
- Kroppssystem
- Abnormality of the nervous system
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Depression, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test464 gener knyttet til Depression
Endringer i disse genene forårsaker sjeldne tilstander der Depression forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ABCB7ATP binding cassette subfamily B member 7 | Alltid | I 2 tilstander |
| AMACRalpha-methylacyl-CoA racemase | Alltid | I 2 tilstander |
| ARHGEF15Rho guanine nucleotide exchange factor 15 | Alltid | I 1 tilstand |
| COX18cytochrome c oxidase assembly factor COX18 | Alltid | I 1 tilstand |
| CST3cystatin C | Alltid | I 1 tilstand |
| CTSAcathepsin A | Alltid | I 1 tilstand |
| DNAJC5DnaJ heat shock protein family (Hsp40) member C5 | Alltid | I 1 tilstand |
| FDXRferredoxin reductase | Alltid | I 1 tilstand |
| FRYLFRY like transcription coactivator | Alltid | I 1 tilstand |
| ITPR1inositol 1,4,5-trisphosphate receptor type 1 | Alltid | I 1 tilstand |
| LAMB1laminin subunit beta 1 | Alltid | I 1 tilstand |
| LRRC7leucine rich repeat containing 7 | Alltid | I 1 tilstand |
| MAU2MAU2 sister chromatid cohesion factor | Alltid | I 1 tilstand |
| MPV17mitochondrial inner membrane protein MPV17 | Alltid | I 1 tilstand |
| PER3period circadian regulator 3 | Alltid | I 1 tilstand |
| PLP1proteolipid protein 1 | Alltid | I 1 tilstand |
| POLG2DNA polymerase gamma 2, accessory subunit | Alltid | I 2 tilstander |
| RAB3ARAB3A, member RAS oncogene family | Alltid | I 1 tilstand |
| SGCEsarcoglycan epsilon | Alltid | I 2 tilstander |
| STUB1STIP1 homology and U-box containing protein 1 | Alltid | I 1 tilstand |
| ATP7BATPase copper transporting beta | Svært ofte (80–99 %) | I 1 tilstand |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Svært ofte (80–99 %) | I 1 tilstand |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Svært ofte (80–99 %) | I 1 tilstand |
| CASRcalcium sensing receptor | Svært ofte (80–99 %) | I 1 tilstand |
| CD4CD4 molecule | Svært ofte (80–99 %) | I 1 tilstand |
| CLIP2CAP-Gly domain containing linker protein 2 | Svært ofte (80–99 %) | I 1 tilstand |
| DCTN1dynactin subunit 1 | Svært ofte (80–99 %) | I 3 tilstander |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Svært ofte (80–99 %) | I 1 tilstand |
| EIF4Heukaryotic translation initiation factor 4H | Svært ofte (80–99 %) | I 1 tilstand |
| ELNelastin | Svært ofte (80–99 %) | I 1 tilstand |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Svært ofte (80–99 %) | I 1 tilstand |
| GNA11G protein subunit alpha 11 | Svært ofte (80–99 %) | I 1 tilstand |
| GTF2Igeneral transcription factor IIi | Svært ofte (80–99 %) | I 1 tilstand |
| GTF2IRD1GTF2I repeat domain containing 1 | Svært ofte (80–99 %) | I 1 tilstand |
| GTF2IRD2GTF2I repeat domain containing 2 | Svært ofte (80–99 %) | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Svært ofte (80–99 %) | I 1 tilstand |
| LIMK1LIM domain kinase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| METTL27methyltransferase like 27 | Svært ofte (80–99 %) | I 1 tilstand |
| NCF1neutrophil cytosolic factor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Svært ofte (80–99 %) | I 1 tilstand |
Vis 424 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| PRNPprion protein (Kanno blood group) | Svært ofte (80–99 %) | I 7 tilstander |
| RFC2replication factor C subunit 2 | Svært ofte (80–99 %) | I 1 tilstand |
| STX1Asyntaxin 1A | Svært ofte (80–99 %) | I 2 tilstander |
| TBL2transducin beta like 2 | Svært ofte (80–99 %) | I 1 tilstand |
| TMEM270transmembrane protein 270 | Svært ofte (80–99 %) | I 1 tilstand |
| VPS37DVPS37D subunit of ESCRT-I | Svært ofte (80–99 %) | I 1 tilstand |
| WFS1wolframin ER transmembrane glycoprotein | Svært ofte (80–99 %) | I 2 tilstander |
| AARS2alanyl-tRNA synthetase 2, mitochondrial | Ofte (30–79 %) | I 1 tilstand |
| AIPAHR interacting HSP90 co-chaperone | Ofte (30–79 %) | I 1 tilstand |
| ANGangiogenin | Ofte (30–79 %) | I 1 tilstand |
| ANXA11annexin A11 | Ofte (30–79 %) | I 1 tilstand |
| ARL6ARF like GTPase 6 | Ofte (30–79 %) | I 1 tilstand |
| ARMC5armadillo repeat containing 5 | Ofte (30–79 %) | I 2 tilstander |
| ATMATM serine/threonine kinase | Ofte (30–79 %) | I 1 tilstand |
| ATP9AATPase phospholipid transporting 9A | Ofte (30–79 %) | I 1 tilstand |
| ATXN2ataxin 2 | Ofte (30–79 %) | I 2 tilstander |
| BBIP1BBSome interacting protein 1 | Ofte (30–79 %) | I 1 tilstand |
| BBS1Bardet-Biedl syndrome 1 | Ofte (30–79 %) | I 1 tilstand |
| BBS10Bardet-Biedl syndrome 10 | Ofte (30–79 %) | I 1 tilstand |
| BBS12Bardet-Biedl syndrome 12 | Ofte (30–79 %) | I 1 tilstand |
| BBS2Bardet-Biedl syndrome 2 | Ofte (30–79 %) | I 1 tilstand |
| BBS4Bardet-Biedl syndrome 4 | Ofte (30–79 %) | I 1 tilstand |
| BBS5Bardet-Biedl syndrome 5 | Ofte (30–79 %) | I 1 tilstand |
| BBS7Bardet-Biedl syndrome 7 | Ofte (30–79 %) | I 1 tilstand |
| BBS9Bardet-Biedl syndrome 9 | Ofte (30–79 %) | I 1 tilstand |
| BMPR1Abone morphogenetic protein receptor type 1A | Ofte (30–79 %) | I 1 tilstand |
| BRCA2BRCA2 DNA repair associated | Ofte (30–79 %) | I 1 tilstand |
| CACNA1Gcalcium voltage-gated channel subunit alpha1 G | Ofte (30–79 %) | I 2 tilstander |
| CCNFcyclin F | Ofte (30–79 %) | I 1 tilstand |
| CDONcell adhesion associated, oncogene regulated | Ofte (30–79 %) | I 4 tilstander |
| CEP19centrosomal protein 19 | Ofte (30–79 %) | I 1 tilstand |
| CEP290centrosomal protein 290 | Ofte (30–79 %) | I 1 tilstand |
| CFAP410cilia and flagella associated protein 410 | Ofte (30–79 %) | I 1 tilstand |
| CFAP418cilia and flagella associated protein 418 | Ofte (30–79 %) | I 1 tilstand |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Ofte (30–79 %) | I 2 tilstander |
| CHD7chromodomain helicase DNA binding protein 7 | Ofte (30–79 %) | I 1 tilstand |
| CHEK2checkpoint kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| CHMP2Bcharged multivesicular body protein 2B | Ofte (30–79 %) | I 2 tilstander |
| COL7A1collagen type VII alpha 1 chain | Ofte (30–79 %) | I 2 tilstander |
| COQ2coenzyme Q2, polyprenyltransferase | Ofte (30–79 %) | I 2 tilstander |
| CRIPTOcripto, EGF-CFC family member | Ofte (30–79 %) | I 4 tilstander |
| DAOD-amino acid oxidase | Ofte (30–79 %) | I 1 tilstand |
| DISP1dispatched RND transporter family member 1 | Ofte (30–79 %) | I 4 tilstander |
| DLL1delta like canonical Notch ligand 1 | Ofte (30–79 %) | I 4 tilstander |
| DNA2DNA replication helicase/nuclease 2 | Ofte (30–79 %) | I 2 tilstander |
| DNAJC6DnaJ heat shock protein family (Hsp40) member C6 | Ofte (30–79 %) | I 1 tilstand |
| DNMT1DNA methyltransferase 1 | Ofte (30–79 %) | I 2 tilstander |
| DRD2dopamine receptor D2 | Ofte (30–79 %) | I 1 tilstand |
| DUSP6dual specificity phosphatase 6 | Ofte (30–79 %) | I 1 tilstand |
| EMX2empty spiracles homeobox 2 | Ofte (30–79 %) | I 1 tilstand |
| EPCAMepithelial cell adhesion molecule | Ofte (30–79 %) | I 1 tilstand |
| EPM2AEPM2A glucan phosphatase, laforin | Ofte (30–79 %) | I 1 tilstand |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Ofte (30–79 %) | I 1 tilstand |
| FGF17fibroblast growth factor 17 | Ofte (30–79 %) | I 1 tilstand |
| FGF8fibroblast growth factor 8 | Ofte (30–79 %) | I 5 tilstander |
| FGFR1fibroblast growth factor receptor 1 | Ofte (30–79 %) | I 3 tilstander |
| FIG4FIG4 phosphoinositide 5-phosphatase | Ofte (30–79 %) | I 1 tilstand |
| FLT4fms related receptor tyrosine kinase 4 | Ofte (30–79 %) | I 1 tilstand |
| FMR1fragile X messenger ribonucleoprotein 1 | Ofte (30–79 %) | I 2 tilstander |
| FOXH1forkhead box H1 | Ofte (30–79 %) | I 4 tilstander |
| FUSFUS RNA binding protein | Ofte (30–79 %) | I 2 tilstander |
| GAS1growth arrest specific 1 | Ofte (30–79 %) | I 4 tilstander |
| GCH1GTP cyclohydrolase 1 | Ofte (30–79 %) | I 1 tilstand |
| GDAP2ganglioside induced differentiation associated protein 2 | Ofte (30–79 %) | I 1 tilstand |
| GLE1GLE1 RNA export mediator | Ofte (30–79 %) | I 1 tilstand |
| GLI2GLI family zinc finger 2 | Ofte (30–79 %) | I 4 tilstander |
| GLT8D1glycosyltransferase 8 domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| GNASGNAS complex locus | Ofte (30–79 %) | I 5 tilstander |
| GNRH1gonadotropin releasing hormone 1 | Ofte (30–79 %) | I 1 tilstand |
| GNRHRgonadotropin releasing hormone receptor | Ofte (30–79 %) | I 1 tilstand |
| GPR101G protein-coupled receptor 101 | Ofte (30–79 %) | I 1 tilstand |
| GPRC5BG protein-coupled receptor class C group 5 member B | Ofte (30–79 %) | I 1 tilstand |
| GRNgranulin precursor | Ofte (30–79 %) | I 1 tilstand |
| GUK1guanylate kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Ofte (30–79 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Ofte (30–79 %) | I 4 tilstander |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Ofte (30–79 %) | I 1 tilstand |
| HS6ST1heparan sulfate 6-O-sulfotransferase 1 | Ofte (30–79 %) | I 1 tilstand |
| HTRA2HtrA serine peptidase 2 | Ofte (30–79 %) | I 1 tilstand |
| HTThuntingtin | Ofte (30–79 %) | I 3 tilstander |
| IDUAalpha-L-iduronidase | Ofte (30–79 %) | I 1 tilstand |
| IFNGinterferon gamma | Ofte (30–79 %) | I 1 tilstand |
| IFT172intraflagellar transport 172 | Ofte (30–79 %) | I 1 tilstand |
| IFT27intraflagellar transport 27 | Ofte (30–79 %) | I 1 tilstand |
| IFT74intraflagellar transport 74 | Ofte (30–79 %) | I 1 tilstand |
| IMPDH2inosine monophosphate dehydrogenase 2 | Ofte (30–79 %) | I 1 tilstand |
| KCTD17potassium channel tetramerization domain containing 17 | Ofte (30–79 %) | I 2 tilstander |
| KDM1Alysine demethylase 1A | Ofte (30–79 %) | I 1 tilstand |
| KISS1KiSS-1 metastasis suppressor | Ofte (30–79 %) | I 1 tilstand |
| KISS1RKISS1 receptor | Ofte (30–79 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Ofte (30–79 %) | I 1 tilstand |
| LRP12LDL receptor related protein 12 | Ofte (30–79 %) | I 1 tilstand |
| LRRK2leucine rich repeat kinase 2 | Ofte (30–79 %) | I 2 tilstander |
| LZTFL1leucine zipper transcription factor like 1 | Ofte (30–79 %) | I 1 tilstand |
| MAPTmicrotubule associated protein tau | Ofte (30–79 %) | I 3 tilstander |
| MATR3matrin 3 | Ofte (30–79 %) | I 1 tilstand |
| MKKSMKKS centrosomal shuttling protein | Ofte (30–79 %) | I 1 tilstand |
| MKS1MKS transition zone complex subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| MLH1mutL homolog 1 | Ofte (30–79 %) | I 1 tilstand |
| MMP1matrix metallopeptidase 1 | Ofte (30–79 %) | I 1 tilstand |
| MSH2mutS homolog 2 | Ofte (30–79 %) | I 1 tilstand |
| MSH6mutS homolog 6 | Ofte (30–79 %) | I 1 tilstand |
| MSTO1misato mitochondrial distribution and morphology regulator 1 | Ofte (30–79 %) | I 2 tilstander |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Ofte (30–79 %) | I 1 tilstand |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Ofte (30–79 %) | I 1 tilstand |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Ofte (30–79 %) | I 1 tilstand |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Ofte (30–79 %) | I 1 tilstand |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Ofte (30–79 %) | I 1 tilstand |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Ofte (30–79 %) | I 1 tilstand |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Ofte (30–79 %) | I 1 tilstand |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Ofte (30–79 %) | I 1 tilstand |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Ofte (30–79 %) | I 2 tilstander |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Ofte (30–79 %) | I 1 tilstand |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Ofte (30–79 %) | I 2 tilstander |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Ofte (30–79 %) | I 2 tilstander |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Ofte (30–79 %) | I 1 tilstand |
| MUTYHmutY DNA glycosylase | Ofte (30–79 %) | I 1 tilstand |
| NEFHneurofilament heavy chain | Ofte (30–79 %) | I 1 tilstand |
| NEK1NIMA related kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| NHLH2nescient helix-loop-helix 2 | Ofte (30–79 %) | I 1 tilstand |
| NHLRC1NHL repeat containing E3 ubiquitin protein ligase 1 | Ofte (30–79 %) | I 1 tilstand |
| NODALnodal growth differentiation factor | Ofte (30–79 %) | I 4 tilstander |
| NPATnuclear protein, coactivator of histone transcription | Ofte (30–79 %) | I 1 tilstand |
| NPHP1nephrocystin 1 | Ofte (30–79 %) | I 1 tilstand |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Ofte (30–79 %) | I 2 tilstander |
| NSMFNMDA receptor synaptonuclear signaling and neuronal migration factor | Ofte (30–79 %) | I 1 tilstand |
| OPTNoptineurin | Ofte (30–79 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Ofte (30–79 %) | I 1 tilstand |
| PANK2pantothenate kinase 2 | Ofte (30–79 %) | I 2 tilstander |
| PARK7Parkinsonism associated deglycase | Ofte (30–79 %) | I 1 tilstand |
| PDGFRBplatelet derived growth factor receptor beta | Ofte (30–79 %) | I 3 tilstander |
| PFN1profilin 1 | Ofte (30–79 %) | I 1 tilstand |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| PINK1PTEN induced kinase 1 | Ofte (30–79 %) | I 2 tilstander |
| PLA2G6phospholipase A2 group VI | Ofte (30–79 %) | I 2 tilstander |
| PLCH1phospholipase C eta 1 | Ofte (30–79 %) | I 1 tilstand |
| PMS1PMS1 homolog 1, mismatch repair system component | Ofte (30–79 %) | I 1 tilstand |
| PMS2PMS1 homolog 2, mismatch repair system component | Ofte (30–79 %) | I 1 tilstand |
| PODXLpodocalyxin like | Ofte (30–79 %) | I 1 tilstand |
| POLD1DNA polymerase delta 1, catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| POLEDNA polymerase epsilon, catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| POLGDNA polymerase gamma, catalytic subunit | Ofte (30–79 %) | I 7 tilstander |
| PRKNparkin RBR E3 ubiquitin protein ligase | Ofte (30–79 %) | I 1 tilstand |
| PROK2prokineticin 2 | Ofte (30–79 %) | I 1 tilstand |
| PROKR2prokineticin receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| PRPHperipherin | Ofte (30–79 %) | I 1 tilstand |
| PSAPprosaposin | Ofte (30–79 %) | I 2 tilstander |
| PSEN1presenilin 1 | Ofte (30–79 %) | I 1 tilstand |
| PTCH1patched 1 | Ofte (30–79 %) | I 4 tilstander |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Ofte (30–79 %) | I 2 tilstander |
| RAB32RAB32, member RAS oncogene family | Ofte (30–79 %) | I 1 tilstand |
| RPS20ribosomal protein S20 | Ofte (30–79 %) | I 1 tilstand |
| SCAPERS-phase cyclin A associated protein in the ER | Ofte (30–79 %) | I 1 tilstand |
| SCLT1sodium channel and clathrin linker 1 | Ofte (30–79 %) | I 1 tilstand |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Ofte (30–79 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Ofte (30–79 %) | I 1 tilstand |
| SEMA4Asemaphorin 4A | Ofte (30–79 %) | I 1 tilstand |
| SHHsonic hedgehog signaling molecule | Ofte (30–79 %) | I 4 tilstander |
| SIX3SIX homeobox 3 | Ofte (30–79 %) | I 4 tilstander |
| SLC2A3solute carrier family 2 member 3 | Ofte (30–79 %) | I 1 tilstand |
| SLC7A6OSsolute carrier family 7 member 6 opposite strand | Ofte (30–79 %) | I 1 tilstand |
| SMC1Astructural maintenance of chromosomes 1A | Ofte (30–79 %) | I 1 tilstand |
| SNCAsynuclein alpha | Ofte (30–79 %) | I 3 tilstander |
| SOD1superoxide dismutase 1 | Ofte (30–79 %) | I 1 tilstand |
| SPRsepiapterin reductase | Ofte (30–79 %) | I 1 tilstand |
| SPRY4sprouty RTK signaling antagonist 4 | Ofte (30–79 %) | I 1 tilstand |
| SQSTM1sequestosome 1 | Ofte (30–79 %) | I 2 tilstander |
| STAG2STAG2 cohesin complex component | Ofte (30–79 %) | I 2 tilstander |
| STILSTIL centriolar assembly protein | Ofte (30–79 %) | I 4 tilstander |
| SYNJ1synaptojanin 1 | Ofte (30–79 %) | I 1 tilstand |
| TAC3tachykinin precursor 3 | Ofte (30–79 %) | I 1 tilstand |
| TACR3tachykinin receptor 3 | Ofte (30–79 %) | I 1 tilstand |
| TAF15TATA-box binding protein associated factor 15 | Ofte (30–79 %) | I 1 tilstand |
| TARDBPTAR DNA binding protein | Ofte (30–79 %) | I 2 tilstander |
| TBK1TANK binding kinase 1 | Ofte (30–79 %) | I 2 tilstander |
| TGFBR2transforming growth factor beta receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| TGIF1TGFB induced factor homeobox 1 | Ofte (30–79 %) | I 4 tilstander |
| TMEM106Btransmembrane protein 106B | Ofte (30–79 %) | I 1 tilstand |
| TOR1Atorsin family 1 member A | Ofte (30–79 %) | I 2 tilstander |
| TPH2tryptophan hydroxylase 2 | Ofte (30–79 %) | I 2 tilstander |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Ofte (30–79 %) | I 1 tilstand |
| TREM2triggering receptor expressed on myeloid cells 2 | Ofte (30–79 %) | I 2 tilstander |
| TRHRthyrotropin releasing hormone receptor | Ofte (30–79 %) | I 1 tilstand |
| TRIM32tripartite motif containing 32 | Ofte (30–79 %) | I 1 tilstand |
| TSC1TSC complex subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| TSC2TSC complex subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| TTC8tetratricopeptide repeat domain 8 | Ofte (30–79 %) | I 1 tilstand |
| UBQLN2ubiquilin 2 | Ofte (30–79 %) | I 1 tilstand |
| UCHL1ubiquitin C-terminal hydrolase L1 | Ofte (30–79 %) | I 1 tilstand |
| UNC13Aunc-13 homolog A | Ofte (30–79 %) | I 1 tilstand |
| UQCRC1ubiquinol-cytochrome c reductase core protein 1 | Ofte (30–79 %) | I 1 tilstand |
| VAPBVAMP associated protein B and C | Ofte (30–79 %) | I 1 tilstand |
| VCPvalosin containing protein | Ofte (30–79 %) | I 5 tilstander |
| VPS13Avacuolar protein sorting 13 homolog A | Ofte (30–79 %) | I 2 tilstander |
| VPS13Cvacuolar protein sorting 13 homolog C | Ofte (30–79 %) | I 2 tilstander |
| WARS2tryptophanyl tRNA synthetase 2, mitochondrial | Ofte (30–79 %) | I 1 tilstand |
| WDPCPWD repeat containing planar cell polarity effector | Ofte (30–79 %) | I 1 tilstand |
| WDR11WD repeat domain 11 | Ofte (30–79 %) | I 1 tilstand |
| ZIC2Zic family zinc finger 2 | Ofte (30–79 %) | I 4 tilstander |
| ABCB11ATP binding cassette subfamily B member 11 | Noen ganger (5–29 %) | I 1 tilstand |
| ABCB4ATP binding cassette subfamily B member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| ADA2adenosine deaminase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ADGRV1adhesion G protein-coupled receptor V1 | Noen ganger (5–29 %) | I 1 tilstand |
| ALADaminolevulinate dehydratase | Noen ganger (5–29 %) | I 1 tilstand |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Noen ganger (5–29 %) | I 1 tilstand |
| AOPEPaminopeptidase O (putative) | Noen ganger (5–29 %) | I 1 tilstand |
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Noen ganger (5–29 %) | I 1 tilstand |
| AP2S1adaptor related protein complex 2 subunit sigma 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ARandrogen receptor | Noen ganger (5–29 %) | I 2 tilstander |
| ARSAarylsulfatase A | Noen ganger (5–29 %) | I 1 tilstand |
| ARSGarylsulfatase G | Noen ganger (5–29 %) | I 1 tilstand |
| ARVCFARVCF delta catenin family member | Noen ganger (5–29 %) | I 1 tilstand |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Noen ganger (5–29 %) | I 2 tilstander |
| ATP2A2ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ATP8B1ATPase phospholipid transporting 8B1 | Noen ganger (5–29 %) | I 1 tilstand |
| ATRXATRX chromatin remodeler | Noen ganger (5–29 %) | I 2 tilstander |
| ATXN10ataxin 10 | Noen ganger (5–29 %) | I 2 tilstander |
| ATXN8ataxin 8 | Noen ganger (5–29 %) | I 1 tilstand |
| ATXN8OSATXN8 opposite strand lncRNA | Noen ganger (5–29 %) | I 2 tilstander |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Noen ganger (5–29 %) | I 1 tilstand |
| BCRBCR activator of RhoGEF and GTPase | Noen ganger (5–29 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| C1Rcomplement C1r | Noen ganger (5–29 %) | I 1 tilstand |
| C1Scomplement C1s | Noen ganger (5–29 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Noen ganger (5–29 %) | I 1 tilstand |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Noen ganger (5–29 %) | I 1 tilstand |
| CABP4calcium binding protein 4 | Noen ganger (5–29 %) | I 1 tilstand |
| CACNA1Hcalcium voltage-gated channel subunit alpha1 H | Noen ganger (5–29 %) | I 1 tilstand |
| CACNA1Icalcium voltage-gated channel subunit alpha1 I | Noen ganger (5–29 %) | I 1 tilstand |
| CARS1cysteinyl-tRNA synthetase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CBScystathionine beta-synthase | Noen ganger (5–29 %) | I 2 tilstander |
| CDH23cadherin related 23 | Noen ganger (5–29 %) | I 2 tilstander |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Noen ganger (5–29 %) | I 1 tilstand |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Noen ganger (5–29 %) | I 1 tilstand |
| CEACAM3CEA cell adhesion molecule 3 | Noen ganger (5–29 %) | I 1 tilstand |
| CEACAM6CEA cell adhesion molecule 6 | Noen ganger (5–29 %) | I 1 tilstand |
| CEP78centrosomal protein 78 | Noen ganger (5–29 %) | I 1 tilstand |
| CEP85Lcentrosomal protein 85L | Noen ganger (5–29 %) | I 1 tilstand |
| CFTRCF transmembrane conductance regulator | Noen ganger (5–29 %) | I 1 tilstand |
| CHCHD2coiled-coil-helix-coiled-coil-helix domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CHD8chromodomain helicase DNA binding protein 8 | Noen ganger (5–29 %) | I 1 tilstand |
| CHRNA2cholinergic receptor nicotinic alpha 2 subunit | Noen ganger (5–29 %) | I 1 tilstand |
| CHRNA4cholinergic receptor nicotinic alpha 4 subunit | Noen ganger (5–29 %) | I 1 tilstand |
| CHRNB2cholinergic receptor nicotinic beta 2 subunit | Noen ganger (5–29 %) | I 1 tilstand |
| CLCA4chloride channel accessory 4 | Noen ganger (5–29 %) | I 1 tilstand |
| CLCN4Cl-/H+ antiporter 4 | Noen ganger (5–29 %) | I 2 tilstander |
| CLRN1clarin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| COMTcatechol-O-methyltransferase | Noen ganger (5–29 %) | I 1 tilstand |
| CR2complement C3d receptor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CRHcorticotropin releasing hormone | Noen ganger (5–29 %) | I 1 tilstand |
| CRKLCRK like proto-oncogene, adaptor protein | Noen ganger (5–29 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Noen ganger (5–29 %) | I 1 tilstand |
| CTSFcathepsin F | Noen ganger (5–29 %) | I 1 tilstand |
| CTSHcathepsin H | Noen ganger (5–29 %) | I 1 tilstand |
| CYP27A1cytochrome P450 family 27 subfamily A member 1 | Noen ganger (5–29 %) | I 1 tilstand |
| DCTN4dynactin subunit 4 | Noen ganger (5–29 %) | I 1 tilstand |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Noen ganger (5–29 %) | I 1 tilstand |
| DGUOKdeoxyguanosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| DNAJC13DnaJ heat shock protein family (Hsp40) member C13 | Noen ganger (5–29 %) | I 1 tilstand |
| DNASE1deoxyribonuclease 1 | Noen ganger (5–29 %) | I 1 tilstand |
| EDNRAendothelin receptor type A | Noen ganger (5–29 %) | I 1 tilstand |
| EHMT1euchromatic histone lysine methyltransferase 1 | Noen ganger (5–29 %) | I 2 tilstander |
| EIF4G1eukaryotic translation initiation factor 4 gamma 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ESPNespin | Noen ganger (5–29 %) | I 1 tilstand |
| ETS1ETS proto-oncogene 1, transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Noen ganger (5–29 %) | I 1 tilstand |
| FCGR3BFc gamma receptor IIIb | Noen ganger (5–29 %) | I 1 tilstand |
| FGF14fibroblast growth factor 14 | Noen ganger (5–29 %) | I 2 tilstander |
| FMO3flavin containing dimethylaniline monoxygenase 3 | Noen ganger (5–29 %) | I 2 tilstander |
| FXNfrataxin | Noen ganger (5–29 %) | I 1 tilstand |
| GABRA1gamma-aminobutyric acid type A receptor subunit alpha1 | Noen ganger (5–29 %) | I 1 tilstand |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Noen ganger (5–29 %) | I 1 tilstand |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Noen ganger (5–29 %) | I 2 tilstander |
| GALTgalactose-1-phosphate uridylyltransferase | Noen ganger (5–29 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Noen ganger (5–29 %) | I 4 tilstander |
| GCLCglutamate-cysteine ligase catalytic subunit | Noen ganger (5–29 %) | I 1 tilstand |
| GIGYF2GRB10 interacting GYF protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| GLAgalactosidase alpha | Noen ganger (5–29 %) | I 1 tilstand |
| GP1BBglycoprotein Ib platelet subunit beta | Noen ganger (5–29 %) | I 1 tilstand |
| GPR35G protein-coupled receptor 35 | Noen ganger (5–29 %) | I 1 tilstand |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Noen ganger (5–29 %) | I 2 tilstander |
| GSTM3glutathione S-transferase mu 3 | Noen ganger (5–29 %) | I 1 tilstand |
| HARS1histidyl-tRNA synthetase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HCRThypocretin neuropeptide precursor | Noen ganger (5–29 %) | I 1 tilstand |
| HFEhomeostatic iron regulator | Noen ganger (5–29 %) | I 1 tilstand |
| HIRAhistone cell cycle regulator | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Noen ganger (5–29 %) | I 4 tilstander |
| HMBShydroxymethylbilane synthase | Noen ganger (5–29 %) | I 2 tilstander |
| HMOX1heme oxygenase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Noen ganger (5–29 %) | I 1 tilstand |
| IL10interleukin 10 | Noen ganger (5–29 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Noen ganger (5–29 %) | I 1 tilstand |
| ITGAMintegrin subunit alpha M | Noen ganger (5–29 %) | I 1 tilstand |
| JAZF1JAZF zinc finger 1 | Noen ganger (5–29 %) | I 1 tilstand |
| JMJD1Cjumonji domain containing 1C | Noen ganger (5–29 %) | I 1 tilstand |
| JRKJrk helix-turn-helix protein | Noen ganger (5–29 %) | I 1 tilstand |
| KCNN4potassium calcium-activated channel subfamily N member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| KCNT1potassium sodium-activated channel subfamily T member 1 | Noen ganger (5–29 %) | I 2 tilstander |
| KIAA0319LKIAA0319 like | Noen ganger (5–29 %) | I 1 tilstand |
| KMT2Blysine methyltransferase 2B | Noen ganger (5–29 %) | I 1 tilstand |
| LAMP2lysosome associated membrane protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| MAMLD1mastermind like domain containing 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MAN2B1mannosidase alpha class 2B member 1 | Noen ganger (5–29 %) | I 2 tilstander |
| MAPK1mitogen-activated protein kinase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Noen ganger (5–29 %) | I 2 tilstander |
| MEFVMEFV innate immunity regulator, pyrin | Noen ganger (5–29 %) | I 1 tilstand |
| MEN1menin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MIFmacrophage migration inhibitory factor | Noen ganger (5–29 %) | I 1 tilstand |
| MOGmyelin oligodendrocyte glycoprotein | Noen ganger (5–29 %) | I 1 tilstand |
| MST1macrophage stimulating 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Noen ganger (5–29 %) | I 1 tilstand |
| MT-TNmitochondrially encoded tRNA-Asn (AAU/C) | Noen ganger (5–29 %) | I 1 tilstand |
| MYO7Amyosin VIIA | Noen ganger (5–29 %) | I 2 tilstander |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Noen ganger (5–29 %) | I 2 tilstander |
| NIT1nitrilase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| NOTCH3notch receptor 3 | Noen ganger (5–29 %) | I 1 tilstand |
| NR1H4nuclear receptor subfamily 1 group H member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Noen ganger (5–29 %) | I 1 tilstand |
| OTCornithine transcarbamylase | Noen ganger (5–29 %) | I 1 tilstand |
| P2RY11purinergic receptor P2Y11 | Noen ganger (5–29 %) | I 1 tilstand |
| PCDH15protocadherin related 15 | Noen ganger (5–29 %) | I 1 tilstand |
| PDCD1programmed cell death 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PDGFBplatelet derived growth factor subunit B | Noen ganger (5–29 %) | I 2 tilstander |
| PDZD7PDZ domain containing 7 | Noen ganger (5–29 %) | I 1 tilstand |
| PTPAprotein phosphatase 2 phosphatase activator | Noen ganger (5–29 %) | I 1 tilstand |
| PTRHD1peptidyl-tRNA hydrolase domain containing 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PTS6-pyruvoyltetrahydropterin synthase | Noen ganger (5–29 %) | I 1 tilstand |
| PXKPX domain containing serine/threonine kinase like | Noen ganger (5–29 %) | I 1 tilstand |
| RPS6KA3ribosomal protein S6 kinase A3 | Noen ganger (5–29 %) | I 1 tilstand |
| RPS6KC1ribosomal protein S6 kinase C1 | Noen ganger (5–29 %) | I 1 tilstand |
| RREB1ras responsive element binding protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| RRM1ribonucleotide reductase catalytic subunit M1 | Noen ganger (5–29 %) | I 1 tilstand |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Noen ganger (5–29 %) | I 2 tilstander |
| SCARB2scavenger receptor class B member 2 | Noen ganger (5–29 %) | I 1 tilstand |
| SEC24CSEC24 homolog C, COPII component | Noen ganger (5–29 %) | I 1 tilstand |
| SEMA4Dsemaphorin 4D | Noen ganger (5–29 %) | I 1 tilstand |
| SERPINA1serpin family A member 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SLC11A1solute carrier family 11 member 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SLC25A4solute carrier family 25 member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| SLC26A9solute carrier family 26 member 9 | Noen ganger (5–29 %) | I 1 tilstand |
| SLC6A14solute carrier family 6 member 14 | Noen ganger (5–29 %) | I 1 tilstand |
| SLC9A3solute carrier family 9 member A3 | Noen ganger (5–29 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SPTBN1spectrin beta, non-erythrocytic 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SRPX2sushi repeat containing protein X-linked 2 | Noen ganger (5–29 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Noen ganger (5–29 %) | I 1 tilstand |
| STX16syntaxin 16 | Noen ganger (5–29 %) | I 1 tilstand |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Noen ganger (5–29 %) | I 1 tilstand |
| TBX1T-box transcription factor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TCF4transcription factor 4 | Noen ganger (5–29 %) | I 1 tilstand |
| TET3tet methylcytosine dioxygenase 3 | Noen ganger (5–29 %) | I 1 tilstand |
| TGFB1transforming growth factor beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| THOC2THO complex subunit 2 | Noen ganger (5–29 %) | I 2 tilstander |
| TK2thymidine kinase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Noen ganger (5–29 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Noen ganger (5–29 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Noen ganger (5–29 %) | I 2 tilstander |
| TNIP1TNFAIP3 interacting protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TOP3ADNA topoisomerase III alpha | Noen ganger (5–29 %) | I 1 tilstand |
| TP53tumor protein p53 | Noen ganger (5–29 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Noen ganger (5–29 %) | I 2 tilstander |
| TWNKtwinkle mtDNA helicase | Noen ganger (5–29 %) | I 4 tilstander |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Noen ganger (5–29 %) | I 1 tilstand |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Noen ganger (5–29 %) | I 1 tilstand |
| USH1CUSH1 protein network component harmonin | Noen ganger (5–29 %) | I 1 tilstand |
| USH1GUSH1 protein network component sans | Noen ganger (5–29 %) | I 1 tilstand |
| USH2Ausherin | Noen ganger (5–29 %) | I 1 tilstand |
| USP48ubiquitin specific peptidase 48 | Noen ganger (5–29 %) | I 1 tilstand |
| USP8ubiquitin specific peptidase 8 | Noen ganger (5–29 %) | I 1 tilstand |
| VPS35VPS35 retromer complex component | Noen ganger (5–29 %) | I 1 tilstand |
| WHRNwhirlin | Noen ganger (5–29 %) | I 1 tilstand |
| ZFXzinc finger protein X-linked | Noen ganger (5–29 %) | I 1 tilstand |
| ZNF365zinc finger protein 365 | Noen ganger (5–29 %) | I 1 tilstand |
| AFG3L2AFG3 like matrix AAA peptidase subunit 2 | Sjelden (1–4%) | I 2 tilstander |
| ATP13A2ATPase cation transporting 13A2 | Sjelden (1–4%) | I 1 tilstand |
| CTCFCCCTC-binding factor | Sjelden (1–4%) | I 1 tilstand |
| FA2Hfatty acid 2-hydroxylase | Sjelden (1–4%) | I 1 tilstand |
| GSNgelsolin | Sjelden (1–4%) | I 1 tilstand |
| KDM6Blysine demethylase 6B | Sjelden (1–4%) | I 1 tilstand |
| LGI1leucine rich glioma inactivated 1 | Sjelden (1–4%) | I 1 tilstand |
| MICAL1microtubule associated monooxygenase, calponin and LIM domain containing 1 | Sjelden (1–4%) | I 1 tilstand |
| RELNreelin | Sjelden (1–4%) | I 1 tilstand |
| SMPD1sphingomyelin phosphodiesterase 1 | Sjelden (1–4%) | I 1 tilstand |
| TSHBthyroid stimulating hormone subunit beta | Sjelden (1–4%) | I 1 tilstand |
| ABCA7ATP binding cassette subfamily A member 7 | Ikke registrert | I 1 tilstand |
| ADH1Calcohol dehydrogenase 1C (class I), gamma polypeptide | Ikke registrert | I 1 tilstand |
| ATXN3ataxin 3 | Ikke registrert | I 1 tilstand |
| BCS1LBCS1 ubiquinol-cytochrome c reductase complex chaperone | Ikke registrert | I 1 tilstand |
| C19orf12chromosome 19 open reading frame 12 | Ikke registrert | I 1 tilstand |
| C9orf72C9orf72-SMCR8 complex subunit | Ikke registrert | I 1 tilstand |
| CISD2CDGSH iron sulfur domain 2 | Ikke registrert | I 1 tilstand |
| CLN6CLN6 transmembrane ER protein | Ikke registrert | I 1 tilstand |
| COASYCoenzyme A synthase | Ikke registrert | I 1 tilstand |
| CPOXcoproporphyrinogen oxidase | Ikke registrert | I 1 tilstand |
| CSF1Rcolony stimulating factor 1 receptor | Ikke registrert | I 1 tilstand |
| FKBP5FKBP prolyl isomerase 5 | Ikke registrert | I 1 tilstand |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Ikke registrert | I 1 tilstand |
| HTR2A5-hydroxytryptamine receptor 2A | Ikke registrert | I 2 tilstander |
| JAM2junctional adhesion molecule 2 | Ikke registrert | I 1 tilstand |
| JPH3junctophilin 3 | Ikke registrert | I 1 tilstand |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Ikke registrert | I 1 tilstand |
| MT-TTmitochondrially encoded tRNA-Thr (ACN) | Ikke registrert | I 1 tilstand |
| MYORGmyogenesis regulating glycosidase | Ikke registrert | I 1 tilstand |
| PAHphenylalanine hydroxylase | Ikke registrert | I 1 tilstand |
| PDE11Aphosphodiesterase 11A | Ikke registrert | I 1 tilstand |
| PER2period circadian regulator 2 | Ikke registrert | I 1 tilstand |
| PPP2R2Bprotein phosphatase 2 regulatory subunit Bbeta | Ikke registrert | I 1 tilstand |
| PPT1palmitoyl-protein thioesterase 1 | Ikke registrert | I 1 tilstand |
| PRKACAprotein kinase cAMP-activated catalytic subunit alpha | Ikke registrert | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Ikke registrert | I 1 tilstand |
| PRKCGprotein kinase C gamma | Ikke registrert | I 1 tilstand |
| SLC20A2solute carrier family 20 member 2 | Ikke registrert | I 1 tilstand |
| SLC6A4solute carrier family 6 member 4 | Ikke registrert | I 1 tilstand |
| SNCAIPsynuclein alpha interacting protein | Ikke registrert | I 1 tilstand |
| SPASTspastin | Ikke registrert | I 1 tilstand |
| TBC1D7TBC1 domain family member 7 | Ikke registrert | I 1 tilstand |
| TBPTATA-box binding protein | Ikke registrert | I 2 tilstander |
| TDO2tryptophan 2,3-dioxygenase | Ikke registrert | I 1 tilstand |
| TTC19tetratricopeptide repeat domain 19 | Ikke registrert | I 1 tilstand |
| XKX-linked Kx blood group antigen, Kell and VPS13A binding protein | Ikke registrert | I 1 tilstand |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Ikke registrert | I 2 tilstander |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker